Researchers Recommend Expanding WHO’s Triple Testing Campaign For HIV, HBV, And HCV

Healio (1/23, Stulpin) reports, “WHO’s triple testing campaign” for HIV, HBV, and HCV “should be expanded across populations and not just to the three groups WHO listed to be most at risk, according to a study” published in Open Forum Infectious Diseases. The researchers “determined that through triple testing, for every case of HIV identified, five would be diagnosed with HBV and three with HCV. They also said that triple testing would not be too costly because testing for all three viruses is available for $2.48 compared with the average cost of $1.00 for the lowest-priced isolated HIV test.”